Paul Appelbaum, MD: What to Warn Patients When Prescribing P

In an interview, Paul Appelbaum, MD, discussed issues clinicians will need to bring up to their patients if the FDA approves a psychedelic-assisted therapy.

Related Keywords

New York , United States , Columbia University , American , Paul Appelbaum , American Psychiatric Association , Drug Administration , Psychedelic Compounds , Assisted Therapy , Therapeutic Psilocybin Are , Psychedelics ,